sales@marketresearchvision.com

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports


Global Genetic Engineering Drug Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global Genetic Engineering Drug Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Category : Pharmaceuticals and Healthcare QY Research Pages :118
Published Date : 2020-12-15

 

Covid-19

COVID-19

Understand the influence of COVID-19 on the Genetic Engineering Drug Market with our analysts monitoring the situation across the globe.
Genetic Engineering Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Genetic Engineering Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026. Segment by Type, the Genetic Engineering Drug market is segmented into Monoclonal Antibody Recombinant Human Erythropoietin Recombinant Human Interferon Recombinant Human Growth Hormone Recombinant Human Insulin Segment by Application, the Genetic Engineering Drug market is segmented into Below 30 Years Old 30 Years Old-60 Years Old Above 60 Years Old Regional and Country-level Analysis The Genetic Engineering Drug market is analysed and market size information is provided by regions (countries). The key regions covered in the Genetic Engineering Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026. Competitive Landscape and Genetic Engineering Drug Market Share Analysis Genetic Engineering Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Genetic Engineering Drug business, the date to enter into the Genetic Engineering Drug market, Genetic Engineering Drug product introduction, recent developments, etc. The major vendors covered: Shanghai Lansheng Guojian Pharmaceutical Biotech Pharmaceutical Anhui Anke Biotechnology GeneScience Pharmaceuticals Beijing SL Pharmaceutical Jiangsu Sihuan Bioengineering Shenzhen Neptunus Interlong Bio-Technique 3SBio Tonghua Dongbao Pharmaceutical
1 Study Coverage 1.1 Genetic Engineering Drug Product Introduction 1.2 Market Segments 1.3 Key Genetic Engineering Drug Manufacturers Covered: Ranking by Revenue 1.4 Market by Type 1.4.1 Global Genetic Engineering Drug Market Size Growth Rate by Type 1.4.2 Monoclonal Antibody 1.4.3 Recombinant Human Erythropoietin 1.4.4 Recombinant Human Interferon 1.4.5 Recombinant Human Growth Hormone 1.4.6 Recombinant Human Insulin 1.5 Market by Application 1.5.1 Global Genetic Engineering Drug Market Size Growth Rate by Application 1.5.2 Below 30 Years Old 1.5.3 30 Years Old-60 Years Old 1.5.4 Above 60 Years Old 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Genetic Engineering Drug Market Size, Estimates and Forecasts 2.1.1 Global Genetic Engineering Drug Revenue 2015-2026 2.1.2 Global Genetic Engineering Drug Sales 2015-2026 2.2 Global Genetic Engineering Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026 2.2.1 Global Genetic Engineering Drug Retrospective Market Scenario in Sales by Region: 2015-2020 2.2.2 Global Genetic Engineering Drug Retrospective Market Scenario in Revenue by Region: 2015-2020 3 Global Genetic Engineering Drug Competitor Landscape by Players 3.1 Genetic Engineering Drug Sales by Manufacturers 3.1.1 Genetic Engineering Drug Sales by Manufacturers (2015-2020) 3.1.2 Genetic Engineering Drug Sales Market Share by Manufacturers (2015-2020) 3.2 Genetic Engineering Drug Revenue by Manufacturers 3.2.1 Genetic Engineering Drug Revenue by Manufacturers (2015-2020) 3.2.2 Genetic Engineering Drug Revenue Share by Manufacturers (2015-2020) 3.2.3 Global Genetic Engineering Drug Market Concentration Ratio (CR5 and HHI) (2015-2020) 3.2.4 Global Top 10 and Top 5 Companies by Genetic Engineering Drug Revenue in 2019 3.2.5 Global Genetic Engineering Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Genetic Engineering Drug Price by Manufacturers 3.4 Genetic Engineering Drug Manufacturing Base Distribution, Product Types 3.4.1 Genetic Engineering Drug Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Genetic Engineering Drug Product Type 3.4.3 Date of International Manufacturers Enter into Genetic Engineering Drug Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Market Size by Type (2015-2026) 4.1 Global Genetic Engineering Drug Market Size by Type (2015-2020) 4.1.1 Global Genetic Engineering Drug Sales by Type (2015-2020) 4.1.2 Global Genetic Engineering Drug Revenue by Type (2015-2020) 4.1.3 Genetic Engineering Drug Average Selling Price (ASP) by Type (2015-2026) 4.2 Global Genetic Engineering Drug Market Size Forecast by Type (2021-2026) 4.2.1 Global Genetic Engineering Drug Sales Forecast by Type (2021-2026) 4.2.2 Global Genetic Engineering Drug Revenue Forecast by Type (2021-2026) 4.2.3 Genetic Engineering Drug Average Selling Price (ASP) Forecast by Type (2021-2026) 4.3 Global Genetic Engineering Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Market Size by Application (2015-2026) 5.1 Global Genetic Engineering Drug Market Size by Application (2015-2020) 5.1.1 Global Genetic Engineering Drug Sales by Application (2015-2020) 5.1.2 Global Genetic Engineering Drug Revenue by Application (2015-2020) 5.1.3 Genetic Engineering Drug Price by Application (2015-2020) 5.2 Genetic Engineering Drug Market Size Forecast by Application (2021-2026) 5.2.1 Global Genetic Engineering Drug Sales Forecast by Application (2021-2026) 5.2.2 Global Genetic Engineering Drug Revenue Forecast by Application (2021-2026) 5.2.3 Global Genetic Engineering Drug Price Forecast by Application (2021-2026) 6 North America 6.1 North America Genetic Engineering Drug by Country 6.1.1 North America Genetic Engineering Drug Sales by Country 6.1.2 North America Genetic Engineering Drug Revenue by Country 6.1.3 U.S. 6.1.4 Canada 6.2 North America Genetic Engineering Drug Market Facts & Figures by Type 6.3 North America Genetic Engineering Drug Market Facts & Figures by Application 7 Europe 7.1 Europe Genetic Engineering Drug by Country 7.1.1 Europe Genetic Engineering Drug Sales by Country 7.1.2 Europe Genetic Engineering Drug Revenue by Country 7.1.3 Germany 7.1.4 France 7.1.5 U.K. 7.1.6 Italy 7.1.7 Russia 7.2 Europe Genetic Engineering Drug Market Facts & Figures by Type 7.3 Europe Genetic Engineering Drug Market Facts & Figures by Application 8 Asia Pacific 8.1 Asia Pacific Genetic Engineering Drug by Region 8.1.1 Asia Pacific Genetic Engineering Drug Sales by Region 8.1.2 Asia Pacific Genetic Engineering Drug Revenue by Region 8.1.3 China 8.1.4 Japan 8.1.5 South Korea 8.1.6 India 8.1.7 Australia 8.1.8 Taiwan 8.1.9 Indonesia 8.1.10 Thailand 8.1.11 Malaysia 8.1.12 Philippines 8.1.13 Vietnam 8.2 Asia Pacific Genetic Engineering Drug Market Facts & Figures by Type 8.3 Asia Pacific Genetic Engineering Drug Market Facts & Figures by Application 9 Latin America 9.1 Latin America Genetic Engineering Drug by Country 9.1.1 Latin America Genetic Engineering Drug Sales by Country 9.1.2 Latin America Genetic Engineering Drug Revenue by Country 9.1.3 Mexico 9.1.4 Brazil 9.1.5 Argentina 9.2 Central & South America Genetic Engineering Drug Market Facts & Figures by Type 9.3 Central & South America Genetic Engineering Drug Market Facts & Figures by Application 10 Middle East and Africa 10.1 Middle East and Africa Genetic Engineering Drug by Country 10.1.1 Middle East and Africa Genetic Engineering Drug Sales by Country 10.1.2 Middle East and Africa Genetic Engineering Drug Revenue by Country 10.1.3 Turkey 10.1.4 Saudi Arabia 10.1.5 U.A.E 10.2 Middle East and Africa Genetic Engineering Drug Market Facts & Figures by Type 10.3 Middle East and Africa Genetic Engineering Drug Market Facts & Figures by Application 11 Company Profiles 11.1 Shanghai Lansheng Guojian Pharmaceutical 11.1.1 Shanghai Lansheng Guojian Pharmaceutical Corporation Information 11.1.2 Shanghai Lansheng Guojian Pharmaceutical Description and Business Overview 11.1.3 Shanghai Lansheng Guojian Pharmaceutical Sales, Revenue and Gross Margin (2015-2020) 11.1.4 Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Products Offered 11.1.5 Shanghai Lansheng Guojian Pharmaceutical Related Developments 11.2 Biotech Pharmaceutical 11.2.1 Biotech Pharmaceutical Corporation Information 11.2.2 Biotech Pharmaceutical Description and Business Overview 11.2.3 Biotech Pharmaceutical Sales, Revenue and Gross Margin (2015-2020) 11.2.4 Biotech Pharmaceutical Genetic Engineering Drug Products Offered 11.2.5 Biotech Pharmaceutical Related Developments 11.3 Anhui Anke Biotechnology 11.3.1 Anhui Anke Biotechnology Corporation Information 11.3.2 Anhui Anke Biotechnology Description and Business Overview 11.3.3 Anhui Anke Biotechnology Sales, Revenue and Gross Margin (2015-2020) 11.3.4 Anhui Anke Biotechnology Genetic Engineering Drug Products Offered 11.3.5 Anhui Anke Biotechnology Related Developments 11.4 GeneScience Pharmaceuticals 11.4.1 GeneScience Pharmaceuticals Corporation Information 11.4.2 GeneScience Pharmaceuticals Description and Business Overview 11.4.3 GeneScience Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020) 11.4.4 GeneScience Pharmaceuticals Genetic Engineering Drug Products Offered 11.4.5 GeneScience Pharmaceuticals Related Developments 11.5 Beijing SL Pharmaceutical 11.5.1 Beijing SL Pharmaceutical Corporation Information 11.5.2 Beijing SL Pharmaceutical Description and Business Overview 11.5.3 Beijing SL Pharmaceutical Sales, Revenue and Gross Margin (2015-2020) 11.5.4 Beijing SL Pharmaceutical Genetic Engineering Drug Products Offered 11.5.5 Beijing SL Pharmaceutical Related Developments 11.6 Jiangsu Sihuan Bioengineering 11.6.1 Jiangsu Sihuan Bioengineering Corporation Information 11.6.2 Jiangsu Sihuan Bioengineering Description and Business Overview 11.6.3 Jiangsu Sihuan Bioengineering Sales, Revenue and Gross Margin (2015-2020) 11.6.4 Jiangsu Sihuan Bioengineering Genetic Engineering Drug Products Offered 11.6.5 Jiangsu Sihuan Bioengineering Related Developments 11.7 Shenzhen Neptunus Interlong Bio-Technique 11.7.1 Shenzhen Neptunus Interlong Bio-Technique Corporation Information 11.7.2 Shenzhen Neptunus Interlong Bio-Technique Description and Business Overview 11.7.3 Shenzhen Neptunus Interlong Bio-Technique Sales, Revenue and Gross Margin (2015-2020) 11.7.4 Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Products Offered 11.7.5 Shenzhen Neptunus Interlong Bio-Technique Related Developments 11.8 3SBio 11.8.1 3SBio Corporation Information 11.8.2 3SBio Description and Business Overview 11.8.3 3SBio Sales, Revenue and Gross Margin (2015-2020) 11.8.4 3SBio Genetic Engineering Drug Products Offered 11.8.5 3SBio Related Developments 11.9 Tonghua Dongbao Pharmaceutical 11.9.1 Tonghua Dongbao Pharmaceutical Corporation Information 11.9.2 Tonghua Dongbao Pharmaceutical Description and Business Overview 11.9.3 Tonghua Dongbao Pharmaceutical Sales, Revenue and Gross Margin (2015-2020) 11.9.4 Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Products Offered 11.9.5 Tonghua Dongbao Pharmaceutical Related Developments 11.1 Shanghai Lansheng Guojian Pharmaceutical 11.1.1 Shanghai Lansheng Guojian Pharmaceutical Corporation Information 11.1.2 Shanghai Lansheng Guojian Pharmaceutical Description and Business Overview 11.1.3 Shanghai Lansheng Guojian Pharmaceutical Sales, Revenue and Gross Margin (2015-2020) 11.1.4 Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Products Offered 11.1.5 Shanghai Lansheng Guojian Pharmaceutical Related Developments 12 Future Forecast by Regions (Countries) (2021-2026) 12.1 Genetic Engineering Drug Market Estimates and Projections by Region 12.1.1 Global Genetic Engineering Drug Sales Forecast by Regions 2021-2026 12.1.2 Global Genetic Engineering Drug Revenue Forecast by Regions 2021-2026 12.2 North America Genetic Engineering Drug Market Size Forecast (2021-2026) 12.2.1 North America: Genetic Engineering Drug Sales Forecast (2021-2026) 12.2.2 North America: Genetic Engineering Drug Revenue Forecast (2021-2026) 12.2.3 North America: Genetic Engineering Drug Market Size Forecast by Country (2021-2026) 12.3 Europe Genetic Engineering Drug Market Size Forecast (2021-2026) 12.3.1 Europe: Genetic Engineering Drug Sales Forecast (2021-2026) 12.3.2 Europe: Genetic Engineering Drug Revenue Forecast (2021-2026) 12.3.3 Europe: Genetic Engineering Drug Market Size Forecast by Country (2021-2026) 12.4 Asia Pacific Genetic Engineering Drug Market Size Forecast (2021-2026) 12.4.1 Asia Pacific: Genetic Engineering Drug Sales Forecast (2021-2026) 12.4.2 Asia Pacific: Genetic Engineering Drug Revenue Forecast (2021-2026) 12.4.3 Asia Pacific: Genetic Engineering Drug Market Size Forecast by Region (2021-2026) 12.5 Latin America Genetic Engineering Drug Market Size Forecast (2021-2026) 12.5.1 Latin America: Genetic Engineering Drug Sales Forecast (2021-2026) 12.5.2 Latin America: Genetic Engineering Drug Revenue Forecast (2021-2026) 12.5.3 Latin America: Genetic Engineering Drug Market Size Forecast by Country (2021-2026) 12.6 Middle East and Africa Genetic Engineering Drug Market Size Forecast (2021-2026) 12.6.1 Middle East and Africa: Genetic Engineering Drug Sales Forecast (2021-2026) 12.6.2 Middle East and Africa: Genetic Engineering Drug Revenue Forecast (2021-2026) 12.6.3 Middle East and Africa: Genetic Engineering Drug Market Size Forecast by Country (2021-2026) 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Porter's Five Forces Analysis 13.5 Primary Interviews with Key Genetic Engineering Drug Players (Opinion Leaders) 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Genetic Engineering Drug Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

Get Free Sample

List of Tables Table 1. Genetic Engineering Drug Market Segments Table 2. Ranking of Global Top Genetic Engineering Drug Manufacturers by Revenue (US$ Million) in 2019 Table 3. Global Genetic Engineering Drug Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million) Table 4. Major Manufacturers of Monoclonal Antibody Table 5. Major Manufacturers of Recombinant Human Erythropoietin Table 6. Major Manufacturers of Recombinant Human Interferon Table 7. Major Manufacturers of Recombinant Human Growth Hormone Table 8. Major Manufacturers of Recombinant Human Insulin Table 9. Global Genetic Engineering Drug Market Size Growth Rate by Application 2020-2026 (K Units) Table 10. Global Genetic Engineering Drug Market Size by Region (K Units) & (US$ Million): 2020 VS 2026 Table 11. Global Genetic Engineering Drug Sales by Regions 2015-2020 (K Units) Table 12. Global Genetic Engineering Drug Sales Market Share by Regions (2015-2020) Table 13. Global Genetic Engineering Drug Revenue by Regions 2015-2020 (US$ Million) Table 14. Global Genetic Engineering Drug Sales by Manufacturers (2015-2020) (K Units) Table 15. Global Genetic Engineering Drug Sales Share by Manufacturers (2015-2020) Table 16. Global Genetic Engineering Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020) Table 17. Global Genetic Engineering Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genetic Engineering Drug as of 2019) Table 18. Genetic Engineering Drug Revenue by Manufacturers (2015-2020) (US$ Million) Table 19. Genetic Engineering Drug Revenue Share by Manufacturers (2015-2020) Table 20. Key Manufacturers Genetic Engineering Drug Price (2015-2020) (USD/Unit) Table 21. Genetic Engineering Drug Manufacturers Manufacturing Base Distribution and Headquarters Table 22. Manufacturers Genetic Engineering Drug Product Type Table 23. Date of International Manufacturers Enter into Genetic Engineering Drug Market Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans Table 25. Global Genetic Engineering Drug Sales by Type (2015-2020) (K Units) Table 26. Global Genetic Engineering Drug Sales Share by Type (2015-2020) Table 27. Global Genetic Engineering Drug Revenue by Type (2015-2020) (US$ Million) Table 28. Global Genetic Engineering Drug Revenue Share by Type (2015-2020) Table 29. Genetic Engineering Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Unit) Table 30. Global Genetic Engineering Drug Sales by Application (2015-2020) (K Units) Table 31. Global Genetic Engineering Drug Sales Share by Application (2015-2020) Table 32. North America Genetic Engineering Drug Sales by Country (2015-2020) (K Units) Table 33. North America Genetic Engineering Drug Sales Market Share by Country (2015-2020) Table 34. North America Genetic Engineering Drug Revenue by Country (2015-2020) (US$ Million) Table 35. North America Genetic Engineering Drug Revenue Market Share by Country (2015-2020) Table 36. North America Genetic Engineering Drug Sales by Type (2015-2020) (K Units) Table 37. North America Genetic Engineering Drug Sales Market Share by Type (2015-2020) Table 38. North America Genetic Engineering Drug Sales by Application (2015-2020) (K Units) Table 39. North America Genetic Engineering Drug Sales Market Share by Application (2015-2020) Table 40. Europe Genetic Engineering Drug Sales by Country (2015-2020) (K Units) Table 41. Europe Genetic Engineering Drug Sales Market Share by Country (2015-2020) Table 42. Europe Genetic Engineering Drug Revenue by Country (2015-2020) (US$ Million) Table 43. Europe Genetic Engineering Drug Revenue Market Share by Country (2015-2020) Table 44. Europe Genetic Engineering Drug Sales by Type (2015-2020) (K Units) Table 45. Europe Genetic Engineering Drug Sales Market Share by Type (2015-2020) Table 46. Europe Genetic Engineering Drug Sales by Application (2015-2020) (K Units) Table 47. Europe Genetic Engineering Drug Sales Market Share by Application (2015-2020) Table 48. Asia Pacific Genetic Engineering Drug Sales by Region (2015-2020) (K Units) Table 49. Asia Pacific Genetic Engineering Drug Sales Market Share by Region (2015-2020) Table 50. Asia Pacific Genetic Engineering Drug Revenue by Region (2015-2020) (US$ Million) Table 51. Asia Pacific Genetic Engineering Drug Revenue Market Share by Region (2015-2020) Table 52. Asia Pacific Genetic Engineering Drug Sales by Type (2015-2020) (K Units) Table 53. Asia Pacific Genetic Engineering Drug Sales Market Share by Type (2015-2020) Table 54. Asia Pacific Genetic Engineering Drug Sales by Application (2015-2020) (K Units) Table 55. Asia Pacific Genetic Engineering Drug Sales Market Share by Application (2015-2020) Table 56. Latin America Genetic Engineering Drug Sales by Country (2015-2020) (K Units) Table 57. Latin America Genetic Engineering Drug Sales Market Share by Country (2015-2020) Table 58. Latin Americaa Genetic Engineering Drug Revenue by Country (2015-2020) (US$ Million) Table 59. Latin America Genetic Engineering Drug Revenue Market Share by Country (2015-2020) Table 60. Latin America Genetic Engineering Drug Sales by Type (2015-2020) (K Units) Table 61. Latin America Genetic Engineering Drug Sales Market Share by Type (2015-2020) Table 62. Latin America Genetic Engineering Drug Sales by Application (2015-2020) (K Units) Table 63. Latin America Genetic Engineering Drug Sales Market Share by Application (2015-2020) Table 64. Middle East and Africa Genetic Engineering Drug Sales by Country (2015-2020) (K Units) Table 65. Middle East and Africa Genetic Engineering Drug Sales Market Share by Country (2015-2020) Table 66. Middle East and Africa Genetic Engineering Drug Revenue by Country (2015-2020) (US$ Million) Table 67. Middle East and Africa Genetic Engineering Drug Revenue Market Share by Country (2015-2020) Table 68. Middle East and Africa Genetic Engineering Drug Sales by Type (2015-2020) (K Units) Table 69. Middle East and Africa Genetic Engineering Drug Sales Market Share by Type (2015-2020) Table 70. Middle East and Africa Genetic Engineering Drug Sales by Application (2015-2020) (K Units) Table 71. Middle East and Africa Genetic Engineering Drug Sales Market Share by Application (2015-2020) Table 72. Shanghai Lansheng Guojian Pharmaceutical Corporation Information Table 73. Shanghai Lansheng Guojian Pharmaceutical Description and Major Businesses Table 74. Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 75. Shanghai Lansheng Guojian Pharmaceutical Product Table 76. Shanghai Lansheng Guojian Pharmaceutical Recent Development Table 77. Biotech Pharmaceutical Corporation Information Table 78. Biotech Pharmaceutical Description and Major Businesses Table 79. Biotech Pharmaceutical Genetic Engineering Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 80. Biotech Pharmaceutical Product Table 81. Biotech Pharmaceutical Recent Development Table 82. Anhui Anke Biotechnology Corporation Information Table 83. Anhui Anke Biotechnology Description and Major Businesses Table 84. Anhui Anke Biotechnology Genetic Engineering Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 85. Anhui Anke Biotechnology Product Table 86. Anhui Anke Biotechnology Recent Development Table 87. GeneScience Pharmaceuticals Corporation Information Table 88. GeneScience Pharmaceuticals Description and Major Businesses Table 89. GeneScience Pharmaceuticals Genetic Engineering Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 90. GeneScience Pharmaceuticals Product Table 91. GeneScience Pharmaceuticals Recent Development Table 92. Beijing SL Pharmaceutical Corporation Information Table 93. Beijing SL Pharmaceutical Description and Major Businesses Table 94. Beijing SL Pharmaceutical Genetic Engineering Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 95. Beijing SL Pharmaceutical Product Table 96. Beijing SL Pharmaceutical Recent Development Table 97. Jiangsu Sihuan Bioengineering Corporation Information Table 98. Jiangsu Sihuan Bioengineering Description and Major Businesses Table 99. Jiangsu Sihuan Bioengineering Genetic Engineering Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 100. Jiangsu Sihuan Bioengineering Product Table 101. Jiangsu Sihuan Bioengineering Recent Development Table 102. Shenzhen Neptunus Interlong Bio-Technique Corporation Information Table 103. Shenzhen Neptunus Interlong Bio-Technique Description and Major Businesses Table 104. Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 105. Shenzhen Neptunus Interlong Bio-Technique Product Table 106. Shenzhen Neptunus Interlong Bio-Technique Recent Development Table 107. 3SBio Corporation Information Table 108. 3SBio Description and Major Businesses Table 109. 3SBio Genetic Engineering Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 110. 3SBio Product Table 111. 3SBio Recent Development Table 112. Tonghua Dongbao Pharmaceutical Corporation Information Table 113. Tonghua Dongbao Pharmaceutical Description and Major Businesses Table 114. Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 115. Tonghua Dongbao Pharmaceutical Product Table 116. Tonghua Dongbao Pharmaceutical Recent Development Table 117. Global Genetic Engineering Drug Sales Forecast by Regions (2021-2026) (K Units) Table 118. Global Genetic Engineering Drug Sales Market Share Forecast by Regions (2021-2026) Table 119. Global Genetic Engineering Drug Revenue Forecast by Regions (2021-2026) (US$ Million) Table 120. Global Genetic Engineering Drug Revenue Market Share Forecast by Regions (2021-2026) Table 121. North America: Genetic Engineering Drug Sales Forecast by Country (2021-2026) (K Units) Table 122. North America: Genetic Engineering Drug Revenue Forecast by Country (2021-2026) (US$ Million) Table 123. Europe: Genetic Engineering Drug Sales Forecast by Country (2021-2026) (K Units) Table 124. Europe: Genetic Engineering Drug Revenue Forecast by Country (2021-2026) (US$ Million) Table 125. Asia Pacific: Genetic Engineering Drug Sales Forecast by Region (2021-2026) (K Units) Table 126. Asia Pacific: Genetic Engineering Drug Revenue Forecast by Region (2021-2026) (US$ Million) Table 127. Latin America: Genetic Engineering Drug Sales Forecast by Country (2021-2026) (K Units) Table 128. Latin America: Genetic Engineering Drug Revenue Forecast by Country (2021-2026) (US$ Million) Table 129. Middle East and Africa: Genetic Engineering Drug Sales Forecast by Country (2021-2026) (K Units) Table 130. Middle East and Africa: Genetic Engineering Drug Revenue Forecast by Country (2021-2026) (US$ Million) Table 131. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 132. Key Challenges Table 133. Market Risks Table 134. Main Points Interviewed from Key Genetic Engineering Drug Players Table 135. Genetic Engineering Drug Customers List Table 136. Genetic Engineering Drug Distributors List Table 137. Research Programs/Design for This Report Table 138. Key Data Information from Secondary Sources Table 139. Key Data Information from Primary Sources List of Figures Figure 1. Genetic Engineering Drug Product Picture Figure 2. Global Genetic Engineering Drug Sales Market Share by Type in 2020 & 2026 Figure 3. Monoclonal Antibody Product Picture Figure 4. Recombinant Human Erythropoietin Product Picture Figure 5. Recombinant Human Interferon Product Picture Figure 6. Recombinant Human Growth Hormone Product Picture Figure 7. Recombinant Human Insulin Product Picture Figure 8. Global Genetic Engineering Drug Sales Market Share by Application in 2020 & 2026 Figure 9. Below 30 Years Old Figure 10. 30 Years Old-60 Years Old Figure 11. Above 60 Years Old Figure 12. Genetic Engineering Drug Report Years Considered Figure 13. Global Genetic Engineering Drug Market Size 2015-2026 (US$ Million) Figure 14. Global Genetic Engineering Drug Sales 2015-2026 (K Units) Figure 15. Global Genetic Engineering Drug Market Size Market Share by Region: 2020 Versus 2026 Figure 16. Global Genetic Engineering Drug Sales Market Share by Region (2015-2020) Figure 17. Global Genetic Engineering Drug Sales Market Share by Region in 2019 Figure 18. Global Genetic Engineering Drug Revenue Market Share by Region (2015-2020) Figure 19. Global Genetic Engineering Drug Revenue Market Share by Region in 2019 Figure 20. Global Genetic Engineering Drug Sales Share by Manufacturer in 2019 Figure 21. The Top 10 and 5 Players Market Share by Genetic Engineering Drug Revenue in 2019 Figure 22. Genetic Engineering Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 23. Global Genetic Engineering Drug Sales Market Share by Type (2015-2020) Figure 24. Global Genetic Engineering Drug Sales Market Share by Type in 2019 Figure 25. Global Genetic Engineering Drug Revenue Market Share by Type (2015-2020) Figure 26. Global Genetic Engineering Drug Revenue Market Share by Type in 2019 Figure 27. Global Genetic Engineering Drug Market Share by Price Range (2015-2020) Figure 28. Global Genetic Engineering Drug Sales Market Share by Application (2015-2020) Figure 29. Global Genetic Engineering Drug Sales Market Share by Application in 2019 Figure 30. Global Genetic Engineering Drug Revenue Market Share by Application (2015-2020) Figure 31. Global Genetic Engineering Drug Revenue Market Share by Application in 2019 Figure 32. North America Genetic Engineering Drug Sales Growth Rate 2015-2020 (K Units) Figure 33. North America Genetic Engineering Drug Revenue Growth Rate 2015-2020 (US$ Million) Figure 34. North America Genetic Engineering Drug Sales Market Share by Country in 2019 Figure 35. North America Genetic Engineering Drug Revenue Market Share by Country in 2019 Figure 36. U.S. Genetic Engineering Drug Sales Growth Rate (2015-2020) (K Units) Figure 37. U.S. Genetic Engineering Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 38. Canada Genetic Engineering Drug Sales Growth Rate (2015-2020) (K Units) Figure 39. Canada Genetic Engineering Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 40. North America Genetic Engineering Drug Market Share by Type in 2019 Figure 41. North America Genetic Engineering Drug Market Share by Application in 2019 Figure 42. Europe Genetic Engineering Drug Sales Growth Rate 2015-2020 (K Units) Figure 43. Europe Genetic Engineering Drug Revenue Growth Rate 2015-2020 (US$ Million) Figure 44. Europe Genetic Engineering Drug Sales Market Share by Country in 2019 Figure 45. Europe Genetic Engineering Drug Revenue Market Share by Country in 2019 Figure 46. Germany Genetic Engineering Drug Sales Growth Rate (2015-2020) (K Units) Figure 47. Germany Genetic Engineering Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 48. France Genetic Engineering Drug Sales Growth Rate (2015-2020) (K Units) Figure 49. France Genetic Engineering Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 50. U.K. Genetic Engineering Drug Sales Growth Rate (2015-2020) (K Units) Figure 51. U.K. Genetic Engineering Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 52. Italy Genetic Engineering Drug Sales Growth Rate (2015-2020) (K Units) Figure 53. Italy Genetic Engineering Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 54. Russia Genetic Engineering Drug Sales Growth Rate (2015-2020) (K Units) Figure 55. Russia Genetic Engineering Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 56. Europe Genetic Engineering Drug Market Share by Type in 2019 Figure 57. Europe Genetic Engineering Drug Market Share by Application in 2019 Figure 58. Asia Pacific Genetic Engineering Drug Sales Growth Rate 2015-2020 (K Units) Figure 59. Asia Pacific Genetic Engineering Drug Revenue Growth Rate 2015-2020 (US$ Million) Figure 60. Asia Pacific Genetic Engineering Drug Sales Market Share by Region in 2019 Figure 61. Asia Pacific Genetic Engineering Drug Revenue Market Share by Region in 2019 Figure 62. China Genetic Engineering Drug Sales Growth Rate (2015-2020) (K Units) Figure 63. China Genetic Engineering Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 64. Japan Genetic Engineering Drug Sales Growth Rate (2015-2020) (K Units) Figure 65. Japan Genetic Engineering Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 66. South Korea Genetic Engineering Drug Sales Growth Rate (2015-2020) (K Units) Figure 67. South Korea Genetic Engineering Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 68. India Genetic Engineering Drug Sales Growth Rate (2015-2020) (K Units) Figure 69. India Genetic Engineering Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 70. Australia Genetic Engineering Drug Sales Growth Rate (2015-2020) (K Units) Figure 71. Australia Genetic Engineering Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 72. Taiwan Genetic Engineering Drug Sales Growth Rate (2015-2020) (K Units) Figure 73. Taiwan Genetic Engineering Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 74. Indonesia Genetic Engineering Drug Sales Growth Rate (2015-2020) (K Units) Figure 75. Indonesia Genetic Engineering Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 76. Thailand Genetic Engineering Drug Sales Growth Rate (2015-2020) (K Units) Figure 77. Thailand Genetic Engineering Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 78. Malaysia Genetic Engineering Drug Sales Growth Rate (2015-2020) (K Units) Figure 79. Malaysia Genetic Engineering Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 80. Philippines Genetic Engineering Drug Sales Growth Rate (2015-2020) (K Units) Figure 81. Philippines Genetic Engineering Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 82. Vietnam Genetic Engineering Drug Sales Growth Rate (2015-2020) (K Units) Figure 83. Vietnam Genetic Engineering Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 84. Asia Pacific Genetic Engineering Drug Market Share by Type in 2019 Figure 85. Asia Pacific Genetic Engineering Drug Market Share by Application in 2019 Figure 86. Latin America Genetic Engineering Drug Sales Growth Rate 2015-2020 (K Units) Figure 87. Latin America Genetic Engineering Drug Revenue Growth Rate 2015-2020 (US$ Million) Figure 88. Latin America Genetic Engineering Drug Sales Market Share by Country in 2019 Figure 89. Latin America Genetic Engineering Drug Revenue Market Share by Country in 2019 Figure 90. Mexico Genetic Engineering Drug Sales Growth Rate (2015-2020) (K Units) Figure 91. Mexico Genetic Engineering Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 92. Brazil Genetic Engineering Drug Sales Growth Rate (2015-2020) (K Units) Figure 93. Brazil Genetic Engineering Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 94. Argentina Genetic Engineering Drug Sales Growth Rate (2015-2020) (K Units) Figure 95. Argentina Genetic Engineering Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 96. Latin America Genetic Engineering Drug Market Share by Type in 2019 Figure 97. Latin America Genetic Engineering Drug Market Share by Application in 2019 Figure 98. Middle East and Africa Genetic Engineering Drug Sales Growth Rate 2015-2020 (K Units) Figure 99. Middle East and Africa Genetic Engineering Drug Revenue Growth Rate 2015-2020 (US$ Million) Figure 100. Middle East and Africa Genetic Engineering Drug Sales Market Share by Country in 2019 Figure 101. Middle East and Africa Genetic Engineering Drug Revenue Market Share by Country in 2019 Figure 102. Turkey Genetic Engineering Drug Sales Growth Rate (2015-2020) (K Units) Figure 103. Turkey Genetic Engineering Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 104. Saudi Arabia Genetic Engineering Drug Sales Growth Rate (2015-2020) (K Units) Figure 105. Saudi Arabia Genetic Engineering Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 106. U.A.E Genetic Engineering Drug Sales Growth Rate (2015-2020) (K Units) Figure 107. U.A.E Genetic Engineering Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 108. Middle East and Africa Genetic Engineering Drug Market Share by Type in 2019 Figure 109. Middle East and Africa Genetic Engineering Drug Market Share by Application in 2019 Figure 110. North America Genetic Engineering Drug Sales Growth Rate Forecast (2021-2026) (K Units) Figure 111. North America Genetic Engineering Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 112. Europe Genetic Engineering Drug Sales Growth Rate Forecast (2021-2026) (K Units) Figure 113. Europe Genetic Engineering Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 114. Asia Pacific Genetic Engineering Drug Sales Growth Rate Forecast (2021-2026) (K Units) Figure 115. Asia Pacific Genetic Engineering Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 116. Latin America Genetic Engineering Drug Sales Growth Rate Forecast (2021-2026) (K Units) Figure 117. Latin America Genetic Engineering Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 118. Middle East and Africa Genetic Engineering Drug Sales Growth Rate Forecast (2021-2026) (K Units) Figure 119. Middle East and Africa Genetic Engineering Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 120. Porter's Five Forces Analysis Figure 121. Channels of Distribution Figure 122. Distributors Profiles Figure 123. Bottom-up and Top-down Approaches for This Report Figure 124. Data Triangulation Figure 125. Key Executives Interviewed

Get Free Sample

Related Reports

Global Genetic Engineering Drug Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global Cushing's Syndrome Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most ...
read more

Global Genetic Engineering Drug Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global Tyrosine Kinase Inhibitors Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Tyrosine kinase inhibitors are small molecules that bind to the receptor site of the kinase enzyme available at cell surface. Scope of the Report: The global tyrosine kinase inhibitors market is e ...
read more

Global Genetic Engineering Drug Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global 2D Chromatography Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

2D chromatography is a type of chromatographic technique in which the injected sample is separated by passing through two different separation stages. This is done by injecting the eluent from the fir ...
read more

Global Genetic Engineering Drug Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global Astringent Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Astringent are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure. Scope of the Report: In 2018, North America is expected to account for th ...
read more

Global Genetic Engineering Drug Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global Disintegrants Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Disintegrants are agents added to tablet (and some encapsulated) formulations to promote the breakup of the tablet (and capsule “slugs') into smaller fragments in an aqueous environment thereby ...
read more


Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Multi User - This is a 1-5 user licence, allowing up to five users have access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.


Cards For Payment

Why Choose us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports
  • Data Security
  • Your data is safe and secure
  • Vast Report Database
  • We have more than 2 Million reports in our database
  • Client Focused
  • Personalized updates and 24*7 support
  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support
  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
-Marketing Manager at a pharma company in Belgium

How To Reach Us

Reach out to our most senior Sales Professional-
Jay Matthews

+1 513 549 5911 (U.S.),
    +44 203 318 2846 (U.K.)
sales@marketresearchvision.com
 

Our Clients






Market Research Vision

About Us


Market Research Vision is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports. Serving as a market research firm, we help our clients in finding: what’s next? We believe in finding creative and innovative solutions through customized and syndicated research reports.
Read More


Contact Us


 
sales@marketresearchvision.com


+1 513 549 5911 (U.S.)
+44 203 318 2846 (U.K.)